Daxxify vs Botox in Ashburn Virginia

Reston Derm in February 2017 January 5, 2024

Daxxify vs Botox in Ashburn Virginia, which is right for you? Both are a great way to banish your wrinkles and fine lines! Towards the end of 2022, the FDA granted approval for Daxxify, an injectable comparable to Botox, designed for the reduction of facial wrinkles and lines in adult women and men. Belonging to the family of aesthetic injectables known as neuromodulators, which also includes Botox, Dysport, Jeuveau, and Xeomin, Daxxify shares similarities with these established injectables, albeit with slight variations due to its unique formulation. Despite its recent FDA approval, Daxxify, or “Daxi,” is currently only available in limited select markets and offices.

What is Daxxify?

Daxxify, also known as “Daxi,” falls within the category of neuromodulators, similar to well-known brands like Botox, Dysport, Jeuveau, and Xeomin. What sets it apart is the inclusion of a peptide attached to the neurotoxin, enhancing the absorption of the active ingredient by muscles.

This injectable is utilized for addressing frown lines, forehead wrinkles, crow’s feet, neck bands, and various dynamic wrinkles, akin to established neurotoxins. Additionally, it can alleviate sweating in palms and armpits and aid in reducing grinding or TMJ symptoms. Notably, clinical trials submitted for FDA approval indicate that 80% of participants experienced benefits for up to 6 months—a duration nearly double that of existing neuromodulators like Botox and Dysport, which typically last 3-4 months. Daxxify provides patients with increased flexibility in selecting a wrinkle treatment tailored to their lifestyle due to its extended duration of results, making it particularly suitable for individuals with busy lifestyles seeking easier maintenance.

Daxxify vs Botox

Every neurotoxin relies on proteins to facilitate the penetration of targeted muscles and wrinkles, with Botox and Dysport employing specific accessory proteins for this purpose. In a groundbreaking development, Daxxify emerged as the first neuromodulator utilizing a distinctive peptide to extend its duration. Uniquely formulated without albumin, Daxxify claims the distinction of being the first and only vegan neurotoxin currently available in the market.

Originally conceived as a topical alternative to provide Botox-like benefits, Daxi or Daxxify incorporates a peptide attached to the neurotoxin to enhance product absorption into the skin and muscles. Although the topical variant did not achieve sufficient penetration through the skin, scientists found that their novel formulation delivered superior wrinkle-reducing effects when injected directly into the targeted muscles.

While Daxi doesn’t serve as a substitute for Botox, it presents a new neuromodulator option, enabling a more personalized approach to reducing wrinkles and fine lines for our patients. With its recent FDA approval and notable efficacy, Daxxify introduces an additional choice for addressing dynamic wrinkles and fine lines. If you seek a longer-lasting alternative to Botox, with potential semiannual treatments for maintenance, or if your current Botox duration isn’t meeting your satisfaction, Daxxify could be a viable option worth considering.